caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1689761207

Rony Shimony

Internal MedicineNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Rony Shimony's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MOUNT SINAI HOSPITAL175551
Boston Scientific Cardiac Diagnostic Services, Llc
Independent Diagnostic Testing Facility (IDTF) · Houston, TX
3676
Northwell Health Laboratories
Clinical Laboratory · New Hyde Park, NY
34241
Mark Gardenswartz
Nephrology · New York, NY
26111
LENOX HILL HOSPITAL2555
Daniel Soffer
Interventional Cardiology · Jacksonville, FL
2347
ENZO CLINICAL LABS, INC.1765
Nenad Trubelja
Cardiology · New York, NY
1657
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1628
Matthew Cham
Diagnostic Radiology · Seattle, WA
1535
Joshua Schwimmer
Nephrology · New York, NY
1237
Larry Di Fabrizio
Pulmonary Disease · New York, NY
1126
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
13
Beneficiaries
—
Total drug cost
$58
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Amlodipine Besylate13 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.